Dr. Barry Dworkin

Unpublished, uncontrolled small study claims that experimental exosome treatment shortens recovery time to five days for patients with severe Covid-19. Further human trials required to prove it truly works.

Medical Mythbusting Commentary for February 9, 2021

Source:
Experimental cancer drug could help hospitalised coronavirus patients recover within five days, Israeli trial claims

Related posts:

  1. Interesting approach using monoclonal antibodies to treat Covid-19 infections. However clinical trials must follow to confirm in vitro findings.
  2. Vulnerable populations to be the focus in a new Canadian COVID-19 antibody study.
  3. UBC, Université de Sherbrooke, and Cornell University researchers report a new enzyme-blocking compound delivered in a nasal spray that effectively treats delta variant infection in mice. Human trials dependent on securing funding.
  4. First step studying the outcomes of a one-and-done therapy using pegylated interferon lambda demonstrated that it helped curb severe COVID-19 infection-related hospitalizations.